Global Burden of Heart Failure Attributable to Atrial Fibrillation and Flutter, insights from GBD 2021

ESC Heart Fail. 2026 Mar 30:xvag094. doi: 10.1093/eschf/xvag094. Online ahead of print.ABSTRACTAIMS: To systematically quantify the global, regional, and national burden of heart failure (HF) attributable to atrial fibrillation/flutter (AF/AFL) from 1990 to 2021, and project trends to 2040.METHODS A

Correction: Intracardiac versus transesophageal echocardiography in atrial fibrillation ablation: a systematic review and meta-analysis

No abstractJ Interv Card Electrophysiol. 2026 Mar 30. doi: 10.1007/s10840-026-02317-7. Online ahead of print.NO ABSTRACTPMID:41910894 | DOI:10.1007/s10840-026-02317-7

Impact of atrial fibrillation catheter ablation on primary prevention ICD eligibility in heart failure with reduced ejection fraction: a systematic review and meta-analysis

No abstractJ Interv Card Electrophysiol. 2026 Mar 30. doi: 10.1007/s10840-026-02302-0. Online ahead of print.NO ABSTRACTPMID:41910893 | DOI:10.1007/s10840-026-02302-0

Pulsed-field ablation versus thermal ablation for atrial fibrillation: an updated systematic review and meta -analysis of randomized controlled trials and observational studies with time-to-event analysis

No abstractJ Interv Card Electrophysiol. 2026 Mar 30. doi: 10.1007/s10840-026-02282-1. Online ahead of print.NO ABSTRACTPMID:41910891 | DOI:10.1007/s10840-026-02282-1

Characteristics of rotational activation identified by the novel high-density ExTRa Mapping system

No abstractJ Interv Card Electrophysiol. 2026 Mar 30. doi: 10.1007/s10840-026-02272-3. Online ahead of print.NO ABSTRACTPMID:41910890 | DOI:10.1007/s10840-026-02272-3

Head-to-head comparison of non-invasive markers of atrial cardiomyopathy and their association with arrhythmia recurrence after atrial fibrillation ablation

Clin Res Cardiol. 2026 Mar 30. doi: 10.1007/s00392-026-02908-4. Online ahead of print.ABSTRACTBACKGROUND: Atrial cardiomyopathy (AtCM) represents an important substrate underlying atrial fibrillation (AF), increased arrhythmia recurrence after catheter ablation, and other adverse outcomes. Several n

Impact of the invasively measured flow-gradient pattern on clinical outcomes and ventricular remodeling after transcatheter aortic valve implantation in patients with severe aortic stenosis and preserved ejection fraction

Clin Res Cardiol. 2026 Mar 30. doi: 10.1007/s00392-026-02881-y. Online ahead of print.ABSTRACTAIMS: To investigate clinical outcomes and cardiac remodeling according to cardiac magnetic resonance (CMR) of the invasively measured different flow/gradient entities of severe aortic stenosis (AS) with pr

Impact of catheter ablation for atrial fibrillation on cardiac ventricular electrical activity: assessment of premature ventricular complex burden

Clin Res Cardiol. 2026 Mar 30. doi: 10.1007/s00392-026-02906-6. Online ahead of print.ABSTRACTBACKGROUND: Data on premature ventricular complex (PVC) burden after pulmonary vein isolation (PVI) for atrial fibrillation (AF) are inconsistent and often limited to selected populations.METHODS: We retros

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation

N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMoa2517213. Online ahead of print.ABSTRACTBACKGROUND: For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are unsuita

Pulsed field ablation for atrial fibrillation in patients with heart failure: insight from the ATHENA registrys

Europace. 2026 Mar 30;28(4):euag049. doi: 10.1093/europace/euag049.ABSTRACTAIMS: Data on pulsed-field ablation (PFA) for atrial fibrillation (AF) in patients with heart failure (HF) are limited. To evaluate clinical outcomes of PFA in patients with AF and HF, stratified by HF subtype.METHODS AND RES

Add-on antiplatelet therapy in anticoagulated patients with atrial fibrillation

Int J Cardiol Heart Vasc. 2026 Mar 20;64:101907. doi: 10.1016/j.ijcha.2026.101907. eCollection 2026 Jun.ABSTRACTBACKGROUND: The impact of add-on antiplatelet therapy in patients with atrial fibrillation (AF) on oral anticoagulants (OAC) in real-world clinical practice remains to be investigated.METH

Clinical implications and recurrence rates of first-time catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a nationwide cohort study

Eur Heart J Open. 2026 Mar 13;6(2):oeag046. doi: 10.1093/ehjopen/oeag046. eCollection 2026 Mar.ABSTRACTAIMS: Catheter ablation (CA) for atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM) poses unique challenges due to structural and electrical remodelling. This study examine

Development and Validation of an Explainable Machine Learning Model for Predicting Repeat Catheter Ablation for Atrial Fibrillation: A Single-Center Retrospective Cohort Study

Int J Gen Med. 2026 Mar 23;19:574069. doi: 10.2147/IJGM.S574069. eCollection 2026.ABSTRACTBACKGROUND: Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia worldwide. Catheter ablation is the first-line therapy for symptomatic/refractory AF, yet post-procedural recurrence remai

Predictors of Stroke in Patients With Atrial Fibrillation: A Retrospective Study

Cureus. 2026 Feb 25;18(2):e104243. doi: 10.7759/cureus.104243. eCollection 2026 Feb.ABSTRACTBackground Stroke remains one of the most serious complications of atrial fibrillation (AF) and is associated with substantial long-term disability and mortality worldwide. Objective The objective of this stu

Unexpected Coronary Sinus Embolization of a Leadless Pacemaker due to Initial Device Failure: A Case Report

Clin Case Rep. 2025 Sep 29;13(10):e70984. doi: 10.1002/ccr3.70984. eCollection 2025 Oct.ABSTRACTLeadless pacemakers reduce complications compared to transvenous systems, but device dislodgement and embolization can occur. We report an 81-year-old man with atrial fibrillation and bradycardia who unde

Correction: Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study

Cureus. 2026 Mar 26;18(3):c418. doi: 10.7759/cureus.c418. eCollection 2026 Mar.ABSTRACT[This corrects the article DOI: 10.7759/cureus.104713.].PMID:41908575 | PMC:PMC13032114 | DOI:10.7759/cureus.c418

Diagnostic Accuracy of H2FPEF and HFA-PEFF Algorithms for Heart Failure with Preserved Ejection Fraction (HFpEF): A Systematic Review and Meta-Analysis

J Clin Pract Res. 2026 Feb 10;48(1):9-18. doi: 10.14744/cpr.2026.34561. eCollection 2026 Jan.ABSTRACTOBJECTIVE: Heart failure with preserved ejection fraction (HFpEF) now accounts for the majority of heart failure cases worldwide, and its prevalence continues to rise. Despite this, diagnosis remains

Outcomes after direct thrombectomy versus combined thrombolysis and thrombectomy in acute large artery occlusion stroke with atrial fibrillation

Front Neurol. 2026 Mar 13;17:1780191. doi: 10.3389/fneur.2026.1780191. eCollection 2026.ABSTRACTBACKGROUND: The role of intravenous thrombolysis (IVT) before endovascular thrombectomy (EVT) remains controversial, particularly for patients with acute large vessel occlusion (LVO) due to atrial fibrill

First-in-human experience for cardiac arrhythmia mapping using a novel ultra-high-density globe-shaped catheter from the multicenter COSMOS study

Heart Rhythm O2. 2026 Jan 8;7(3):443-453. doi: 10.1016/j.hroo.2025.11.029. eCollection 2026 Mar.ABSTRACTBACKGROUND: A novel ultra-high-resolution mapping system (Clarysense, Biosense Webster, Inc) has been developed that consists of a 100-electrode deflectable bidirectional basket-shaped high-densit

pECGreview: Using "Not-to-Miss" ECG diagnoses to assess competency of trainees and faculty in ECG interpretation via a weekly online ECG education program

Heart Rhythm O2. 2025 Dec 26;7(3):513-521. doi: 10.1016/j.hroo.2025.12.015. eCollection 2026 Mar.ABSTRACTBACKGROUND: Trainees and practitioners are suboptimal in their pediatric electrocardiogram (pECG) interpretation skills. We have previously validated a pECG educational tool, Pediatric ECG Review

Beyond burden metrics: Wearable photoplethysmography-derived spatiotemporal progression of atrial fibrillation linked to clinical outcomes

Heart Rhythm O2. 2026 Jan 8;7(3):535-544. doi: 10.1016/j.hroo.2025.12.020. eCollection 2026 Mar.ABSTRACTBACKGROUND: Traditional atrial fibrillation (AF) classification lacks dynamic quantification. Current AF burden assessment is constrained by intermittent monitoring and simplistic metrics.OBJECTIV

Attitudes toward the use of technology among patients with atrial fibrillation

No abstractHeart Rhythm O2. 2026 Jan 20;7(3):640-642. doi: 10.1016/j.hroo.2026.01.010. eCollection 2026 Mar.NO ABSTRACTPMID:41908204 | PMC:PMC13031017 | DOI:10.1016/j.hroo.2026.01.010

The gut-heart axis in atrial fibrillation: Pathophysiology, evidence, and therapeutic potential

Heart Rhythm O2. 2025 Oct 31;7(3):581-597. doi: 10.1016/j.hroo.2025.10.013. eCollection 2026 Mar.ABSTRACTBACKGROUND: Recent advances in microbiome research highlight a bidirectional relationship between gut microbiota and atrial fibrillation (AF), the most common sustained arrhythmia worldwide. Gut

A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design

Heart Rhythm O2. 2025 Dec 23;7(3):561-574. doi: 10.1016/j.hroo.2025.12.011. eCollection 2026 Mar.ABSTRACTBACKGROUND: Recent studies have established catheter ablation as a safe and superior alternative to antiarrhythmic drugs (AADs) as a first-line therapy in patients with paroxysmal atrial fibrilla